OBN, the membership organisation that supports innovative life sciences companies,  today announces that Mike Karim, CEO of Oxford Endovascular is the winner of Perfect Pitch, the fast-paced, interactive and lively pitching session which was a highlight of the BioTrinity 2017 conference programme. 

Perfect Pitch involved ten emerging R&D companies pitch in front of a panel of seasoned investors including:

  • Chair: Kate Bingham, Managing Partner, SV Life Sciences (UK)

 

  • Maina Bhaman, Director of Healthcare Investment, Touchstone Innovations (UK)
  • Kreske Nickelsen, General Partner & Chief Executive Officer, Joint Polish Investment Fund  (Poland)
  • Graeme Martin, Founder, HatchBox Bioconsulting LLC (US)
  • Naveed Siddiqi, Partner, Edmond de Rothschild Investment Partners (UK/France)
  • Andrew McLean, Principal Life Sciences Investor, Oxford Science Innovation (UK)
  • Detlev Mennerich, Director and Investment Manager, Boehringer Ingelheim Ventures (Germany)

 

Each of the ten companies gave a strictly timed 3-minute presentation, with the judges selecting Mike Karim, CEO of Oxford Endovascular, Michael Stein, Chairman and CEO of Oxstem, Caroline Barelle, CEO of Elasmogen and Bert Rutten, COO of Lycotec to present in round two. After the final round of 2-minute presentations and further judges’ deliberations, Mike Karim of Oxford Endovascular was awarded the coveted Perfect Pitch winner’s trophy with Caroline Barelle awarded the runners-up position.

Mike Karim’s presentation described the Company’s development plan in metallic mesh tube devices, invented by engineers and clinicians at Oxford University to treat patients suffering from brain aneurysms.  The judges commended him for his clear and convincing presentation style and the quality of his responses to questions asked.

Kate Bingham, Managing Partner, SV life Sciences, said: “This years’ Perfect Pitch session at BioTrinity reflects the high calibre of company showcase presentations we saw at BioTrinity across all fields of life sciences. This fast-paced session is a fantastic platform for emerging entrepreneurs, with Mike Karim being selected based on the quality of his development programme as well as his confidence, style and engaging pitch.”

John Harris, Chief Executive Office of OBN, commented: “We applaud the talented individuals that competed in this year’s Perfect Pitch session, the quality was high and represent some of the most innovative emerging life sciences companies.  Congratulations to Mike Karim, a very worth winner indeed.”

The ten companies that presented their innovation included:

 

Michael Scherz, CEO, Metys Pharmaceuticals AG

Paul Colbon, CEO, Liverpool ChiroChem

Bert Rutten, COO, Lycotec

Mike Karim, CEO, Oxford Endovascular

Tim Mitchell, CEO, Sareum

Charles Potter, CEO, Unguis

Roy Farfara, CSO, Triox Nano

Michael Stein, Chairman and CEO, Oxstem

Will Dracup, CEO, Biosignatures

Caroline Barelle, CEO, Elasmogen

 

Photos available upon request

Contacts

OBN

John Harris, CEO, OBN
Tel: +44 (0)7881 675990
Email: john.harris@obn.org.uk

 

Citigate Dewe Rogerson
Sylvie Berrebi

Tel:  +44 (0)20 7638 9571

Email: Sylvie.Berrebi@citigatedr.co.uk